Clinical Trials Search among the clinical trials we have open at the Vall d'Hebron Research Institute. Recruitment - Any -YesNo Phase - Any -Phase IPhase IIPhase IIIPhase IV Phase Title Sort descending Service Recruitment Phase III A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to… Infectious Yes Phase III A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled… Neurology Yes Phase III A phase 3, randomized, double-blind, placebo-controlled, parallel-arm… General Pediatrics and Specialties No Phase III A Phase 3, Randomized, Double-blind, Placebo-controlled Study of… Pneumology No Phase III A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate… Pneumology No Phase II A Phase II, Multicenter, Double-Blind, Randomised, Placebo-… Hepatology No Phase II A phase IIa, randomized, parallel, double-blind, Placebo Controlled Study… Internal Medicine No Phase II A Phase I/II study of Brigatinib in pediatric and young adult patients… Pediatric Oncohematology No Phase III A PHASE IIIb MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED… Neuroimmunology Yes Phase III A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to… Cardiology Yes Phase II A randomized, double-blind, placebo-controlled, multi-center study… Internal Medicine No Phase III A randomized, double-blind, placebo-controlled, phase 3 study to evaluate the… Hepatology Yes Phase I A Randomized Open-Label Phase 1/2 Study of INCB001158 Combined With… Hematology and Hematotherapy No Phase III A randomized, placebo-controlled, double-blind, multi-center, phase III… RTA ICU Yes Phase II A single-arm, multi-centre trial to evaluate efficacy and safety of… Pediatric Nephrology No Phase I A SINGLE-ARM, OPEN-LABEL, MULTI-CENTRE, PHASE IB STUDY EVALUATING THE… Pediatric Oncohematology No Phase IV Ácido ursOdesoxicólico vS placebO para la PrevenciÓn de… Digestive Yes Phase II An adaptive, Phase 2, double-blind, randomized, placebo-controlled,… Neurology Yes Phase III “An Open-Label Extension Study to Assess the Long-Term Safety of Eplontersen (… Cardiology Yes Phase II AN OPEN-LABEL, LONG TERM SAFETY AND EFFICACY STUDY OF DONIDALORSEN IN THE… Internal Medicine Yes Phase II An Open-Label, Single-Arm Study to Evaluate the Efficacy, Pharmacokinetics, and… General Pediatrics and Specialties No Phase III Antibióticos alternativos orales y?neuropenetrantes?para pacientes con sífilis Infectious No Phase IV ASSURE : Estudio abierto a largo plazo para evaluar la… Hepatology Yes Phase I Bayer 20810 - Estudio en fase I/II del inhibidor de la… Pediatric Oncohematology Yes Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
